Correct usage and dosage of Bortezomib and precautions for taking it

Bortezomib is a commonly used proteasome inhibitor that is widely used in the treatment of multiple myeloma (Multiple Myeloma) and mantle cell lymphoma (Mantle Cell Lymphoma). It achieves anti-tumor effects by inhibiting the proteasome activity in cancer cells, preventing the degradation of intracellular proteins, leading to cell cycle arrest and cancer cell apoptosis. This article will introduce in detail the correct usage and dosage of bortezomib and important matters that need to be paid attention to when taking the drug, to help patients use the drug reasonably and safely.

The dosage of bortezomib varies slightly depending on the treatment plan. The usual dose for adults with multiple myeloma is 1.3 mg/m² body surface area, intravenously or subcutaneously, twice a week, with an interval of at least 72 hours, for 2 consecutive weeks as a course of treatment, with a week off at the 3rd week. The common medication cycle is 21 days, and the treatment course can last for several cycles depending on the patient's tolerance. In addition, the dosage for patients with mantle cell lymphoma is similar to that for multiple myeloma, but the specific regimen is adjusted by the doctor based on the condition. Subcutaneous injection is better tolerated and has fewer side effects than intravenous injection, and subcutaneous injection is more commonly used in clinical practice.

Patients should pay attention to a number of medication safety precautions when using bortezomib. First of all, because the drug may cause neuropathy, patients should closely monitor sensory abnormalities such as numbness and tingling in the hands and feet, provide timely feedback to the doctor, and adjust the dose or suspend medication if necessary. Secondly, bortezomib may cause hematological toxicity such as thrombocytopenia and leukopenia. Blood tests should be performed regularly during treatment to ensure that blood cell counts are within a safe range. Third, because bortezomib also has potential effects on the heart, especially patients with a history of heart disease, cardiac function needs to be monitored during treatment. Finally, this drug may cause side effects such as gastrointestinal discomfort, fatigue, and infection. Patients should pay attention to rest, dietary hygiene, and regular follow-up visits.

The contraindications and interactions of bortezomib also need to be paid attention to. It is contraindicated in those allergic to bortezomib and any ingredients in its preparations. During use, patients should avoid concurrent use of drugs that conflict with its metabolic pathways, such as certain potent enzyme inhibitors or inducers, so as not to affect the plasma concentration and efficacy of bortezomib. In addition, when using concomitant drugs, you should be alert to drug-drug interactions that may aggravate neurotoxicity or increase the risk of infection. If patients are taking anticoagulant drugs at the same time, they should inform their doctor so that the treatment plan can be adjusted. The safety of bortezomib has not been established in pregnant and lactating women and its use is generally not recommended.

A reasonable lifestyle combined with medication is essential to improve treatment effects and reduce side effects. Patients should maintain a balanced diet, ensure adequate rest and appropriate physical exercise to enhance body resistance. Avoid overexertion and contact with sources of infection, and regularly review your condition and liver and kidney function. In addition, patients should strictly abide by the doctor's medication instructions, not stop medication or change the dosage at will, and seek medical treatment promptly if they find abnormal symptoms. The support and care of family members are equally important, helping patients maintain a good treatment mentality and quality of life.

In summary, bortezomib is an important drug for the treatment of multiple myeloma and mantle cell lymphoma. Its correct usage, dosage and medication precautions are directly related to its efficacy and safety. Patients should use drugs rationally under the guidance of professional doctors, closely monitor adverse reactions, and cooperate with appropriate life management to maximize the therapeutic value of drugs and obtain good therapeutic effects.

Reference materials:https://www.drugs.com/seladelpar.html